| Code | 1836A | ||||||||||
| MA number | 88/0271/12-S | ||||||||||
| Product Form: | sol inj 1x250 MBq/1 ml-2,5 GBq/10 ml (liek.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | GE Healthcare B.V., Netherland | ||||||||||
| Therapeutic Class: | 88 - RADIOPHARMACA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 10 hodín | ||||||||||
| Container: | multidose glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 20.06.2012 |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Steripet_03.2019.docx
|
| PIL: |
PIL_Steripet_08.2020.docx
|
| Safety feature | No |
| Data update: | 23.11.2018 |
